Drug recall D-0332-2021
Product
Cefprozil for Oral Suspension USP, 250mg/5mL, packaged as a) 50 mL (when mixed) bottles (NDC 68180-402-01); b) 75 mL (when mixed) bottles (NDC 68180-402-02); and c) 100 mL (when mixed) bottles (NDC 68180-402-03); Rx only, Manufactured for: Lupin Pharmaceutical, Inc., Baltimore, MD 21202; Manufactured by: Lupin Limited, Mandideep 462 046, India.
Reason for recall
Superpotent Drug
Lots and codes
Lot Numbers: a) F801122, exp. date June 2021; b) F801123, exp. date June 2021; c) F801124, exp. date June 2021
Recall details
- Recalling firm
- Lupin Pharmaceuticals Inc., Baltimore, MD
- Quantity
- a) 6,816 bottles; b) 3,960 bottles and c) 7,038 bottles
- Distribution
- Nationwide in the USA and Puerto Rico
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 26, 2021
- Terminated
- December 16, 2021
Related products
- Cefprozil – drug information
- NDC 68180-401 Cefprozil · Cefprozil 125 mg/5mL · Lupin Pharmaceuticals, Inc.
- NDC 68180-402 Cefprozil · Cefprozil 250 mg/5mL · Lupin Pharmaceuticals, Inc.